LabGenius is a biopharmaceutical company developing a next-generation protein therapeutics using a machine learning-driven evolution engine (EVA™). Their protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics. LabGenius is driven by the vision of looking to the future, the next wave of major scientific breakthroughs will be unlocked by technology platforms that are capable of combining the very best of human ingenuity and machine intelligence. Armed with this knowledge, their mission is to accelerate the discovery of next-generation therapeutic antibodies. To do this, they’re pioneering the development of a smart robotic platform (EVA™) that’s capable of designing, conducting and — critically — learning from its own experiments.